Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of AV-1 Against Dengue Virus 3 (DENV-3) Infection [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the safety and efficacy of AV-1 against Dengue virus serotype 3 infection has completed in a controlled human infection model.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue Fever

Drugs mentioned

• AV-1 (AV-1)

Snippet

Sponsor: AbViro LLC | Conditions: DENV-3 Controlled Human Infection Model | Phase 2 | Status: COMPLETED